Cargando…

Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19

Detalles Bibliográficos
Autores principales: Gould, A., Muse, A., Thomson, A., McGrane, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal College of Radiologists. Published by Elsevier Ltd. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833935/
http://dx.doi.org/10.1016/j.clon.2022.11.028
_version_ 1784868348534718464
author Gould, A.
Muse, A.
Thomson, A.
McGrane, J.
author_facet Gould, A.
Muse, A.
Thomson, A.
McGrane, J.
author_sort Gould, A.
collection PubMed
description
format Online
Article
Text
id pubmed-9833935
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Royal College of Radiologists. Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-98339352023-01-12 Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19 Gould, A. Muse, A. Thomson, A. McGrane, J. Clin Oncol (R Coll Radiol) Article The Royal College of Radiologists. Published by Elsevier Ltd. 2023-02 2023-01-12 /pmc/articles/PMC9833935/ http://dx.doi.org/10.1016/j.clon.2022.11.028 Text en Copyright © 2022 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Gould, A.
Muse, A.
Thomson, A.
McGrane, J.
Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
title Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
title_full Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
title_fullStr Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
title_full_unstemmed Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
title_short Retrospective Real-world Evaluation of Enzalutamide in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) during the COVID-19 Pandemic Compared to Docetaxel in mHSPC Pre-COVID-19
title_sort retrospective real-world evaluation of enzalutamide in metastatic hormone sensitive prostate cancer (mhspc) during the covid-19 pandemic compared to docetaxel in mhspc pre-covid-19
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9833935/
http://dx.doi.org/10.1016/j.clon.2022.11.028
work_keys_str_mv AT goulda retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19
AT musea retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19
AT thomsona retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19
AT mcgranej retrospectiverealworldevaluationofenzalutamideinmetastatichormonesensitiveprostatecancermhspcduringthecovid19pandemiccomparedtodocetaxelinmhspcprecovid19